Onderneming Sichuan Kelun Pharmaceutical Co., Ltd.
Aandelen
002422
CNE100000PW7
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,33 CNY | -1,33% |
|
-3,81% | +4,41% |
Vakgebied
- productie en verkoop van farmaceutische producten (98%). De netto-omzet kan per productfamilie worden opgesplitst in injecteerbare geneesmiddelen (56,9%) en andere (43,1%; tabletten, capsules, granules, enz.);
- overige (2%).
China is goed voor 94,6% van de nettoverkoop.
Aantal werknemers: 19 798
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Transfusion
47,1
%
| 9 452 | 50,0 % | 10 109 | 47,1 % | +6,96% |
Non-transfusion
42,2
%
| 8 274 | 43,7 % | 9 057 | 42,2 % | +9,46% |
Research and Development Projects
7,2
%
| 752 | 4,0 % | 1 548 | 7,2 % | +105,95% |
Other
3,4
%
| 435 | 2,3 % | 740 | 3,4 % | +69,88% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
87,9
%
| 17 512 | 92,6 % | 18 866 | 87,9 % | +7,73% |
International
12,1
%
| 1 401 | 7,4 % | 2 588 | 12,1 % | +84,80% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Si Chuan Liu
CEO | Chief Executive Officer | 40 | 26-06-09 |
Ge Xin Liu
FOU | Founder | 73 | 01-01-96 |
De Gui Lai
DFI | Director of Finance/CFO | 52 | 01-01-01 |
Peng Wan
CHM | Chairman | 48 | 01-10-01 |
Xin Huang
IRC | Investor Relations Contact | - | - |
Hao Feng
IRO | Public Communications Contact | 44 | 24-04-14 |
Hong Bo Tan
PRN | Corporate Officer/Principal | 53 | 19-06-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ge Xin Liu
FOU | Founder | 73 | 01-01-96 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 01-05-18 |
Yun Pei Guo
BRD | Director/Board Member | 77 | 22-01-16 |
Si Chuan Liu
CEO | Chief Executive Officer | 40 | 26-06-09 |
Peng Wan
CHM | Chairman | 48 | 01-10-01 |
Guo Sheng He
BRD | Director/Board Member | 56 | 01-05-14 |
Chang Yan Zheng
BRD | Director/Board Member | 50 | 01-01-97 |
Ming Gang Ou
BRD | Director/Board Member | 57 | 24-11-22 |
Shi Chi Ren
BRD | Director/Board Member | 54 | 29-06-21 |
Jin Bo Gao
BRD | Director/Board Member | 64 | 29-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 607 633 156 | 1 074 801 418 ( 66,86 %) | 6 040 983 ( 0,3758 %) | 66,86 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 569 887 643 | 97.52% | 2 882 313 713 $ | |
83 201 712 | 55.62% | 1 831 355 379 $ | |
SSY GROUP LIMITED 20.43% | 606 722 000 | 20.43% | 365 270 913 $ |
45 335 300 | 10.07% | 97 817 710 $ | |
10 716 165 | 0.91% | 47 352 911 $ |
Bedrijfsgegevens
Sichuan Kelun Pharmaceutical Co., Ltd.
36 West Baihua Road Qingyang District
610071, Chengdu
+86 28 8612 7705
http://www.kelun.com![Adres Sichuan Kelun Pharmaceutical Co., Ltd.(002422)](https://cdn.zonebourse.com/static/address/11367147.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,41% | 6,64 mld. | |
+55,32% | 815 mld. | |
+42,96% | 641 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,16% | 242 mld. | |
+2,17% | 224 mld. | |
+13,33% | 218 mld. | |
+8,48% | 168 mld. |
- Beurs
- Aandelen
- Koers 002422
- Onderneming Sichuan Kelun Pharmaceutical Co., Ltd.